Start free
← Back to Current Affairs
Current Affairs · 1 October 2026

Bitter pills: on Court’s intervention, drug pricing

UPSCEditorialsSource: Editorials, Editorial Opinions, Editorial News, The Hindu Opinion | The Hindu
1

Why in News

The Supreme Court has criticised the gap between the price to retailer (PTR) and the maximum retail price (MRP) of certain drugs, including cancer drugs, which in some cases runs up to 1,000%.

2

What is the issue

Since these drugs are not sold over-the-counter, hospitals decide which brand a patient uses; manufacturers inflate the MRP while offering hospitals a low PTR, letting hospitals pocket the difference while patients pay more.

Detailed analysis

The full analysis is in the app

This page is the summary. The detailed analysis of this story covers:

What is the statusWhat are the challengesWhat measuresWhat lies aheadImportant Data PointsKey conceptsPrevious year questions
Open in Quorum IAS